Front Row Advisors’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.59M | Buy |
6,455
+43
| +0.7% | +$18.8K | 0.75% | 36 |
|
|
2026
Q1 | $2.96M | Sell |
6,412
-15
| -0.2% | -$7.59K | 1% | 28 |
|
|
2025
Q4 | $3.64M | Buy |
6,427
+55
| +0.9% | +$29.3K | 1.21% | 20 |
|
|
2025
Q3 | $2.85M | Sell |
6,372
-1,057
| -14% | -$507K | 0.96% | 25 |
|
|
2025
Q2 | $4.04M | Buy |
7,429
+79
| +1% | +$41.3K | 1.4% | 15 |
|
|
2025
Q1 | $3.64M | Hold |
7,350
| – | – | 1.4% | 15 |
|
|
2024
Q4 | $3.84M | Buy |
7,350
+5
| +0.1% | +$2.6K | 1.33% | 16 |
|
|
2024
Q3 | $3.61M | Buy |
7,345
+114
| +2% | +$53.1K | 1.29% | 19 |
|
|
2024
Q2 | $3.22M | Sell |
7,231
-838
| -10% | -$334K | 1.12% | 18 |
|
|
2024
Q1 | $3.22M | Buy |
8,069
+28
| +0.3% | +$10.6K | 1.19% | 21 |
|
|
2023
Q4 | $2.71M | Buy |
8,041
+50
| +0.6% | +$14.9K | 1.25% | 25 |
|
|
2023
Q3 | $2.34M | Buy |
7,991
+286
| +4% | +$89.3K | 1.08% | 25 |
|
|
2023
Q2 | $2.63M | Buy |
7,705
+176
| +2% | +$53.3K | 1.17% | 21 |
|
|
2023
Q1 | $1.92M | Buy |
7,529
+603
| +9% | +$149K | 0.92% | 31 |
|
|
2022
Q4 | $1.84M | Sell |
6,926
-220
| -3% | -$53.6K | 0.95% | 30 |
|
|
2022
Q3 | $1.34M | Sell |
7,146
-73
| -1% | -$15.7K | 0.69% | 48 |
|
|
2022
Q2 | $1.45M | Buy |
7,219
+6
| +0.1% | +$1.41K | 0.71% | 43 |
|
|
2022
Q1 | $2.18M | Buy |
7,213
+355
| +5% | +$104K | 0.88% | 33 |
|
|
2021
Q4 | $2.46M | Buy |
6,858
+249
| +4% | +$85.7K | 0.92% | 30 |
|
|
2021
Q3 | $2.19M | Buy |
6,609
+78
| +1% | +$26.2K | 0.92% | 31 |
|
|
2021
Q2 | $2.3M | Buy |
6,531
+603
| +10% | +$169K | 0.94% | 30 |
|
|
2021
Q1 | $1.46M | Buy |
5,928
+321
| +6% | +$80.8K | 0.71% | 50 |
|
|
2020
Q4 | $1.53M | Buy |
5,607
+51
| +0.9% | +$12.7K | 0.78% | 43 |
|
|
2020
Q3 | $1.35M | Buy |
5,556
+18
| +0.3% | +$4.04K | 0.72% | 47 |
|
|
2020
Q2 | $1.05M | Sell |
5,538
-12
| -0.2% | -$2.15K | 0.65% | 47 |
|
|
2020
Q1 | $945K | Buy |
+5,550
| New | +$1.02M | 0.64% | 47 |
|
|
2019
Q1 | – | Sell |
-30
| Closed | -$5K | – | 1075 |
|
|
2018
Q4 | $5K | Sell |
30
-18
| -38% | -$3.05K | ﹤0.01% | 537 |
|
|
2018
Q3 | $8K | Hold |
48
| – | – | 0.01% | 459 |
|
|
2018
Q2 | $8K | Hold |
48
| – | – | 0.01% | 487 |
|
|
2018
Q1 | $7K | Hold |
48
| – | – | ﹤0.01% | 495 |
|
|
2017
Q4 | $6K | Buy |
+48
| New | +$6.01K | ﹤0.01% | 510 |
|
Other funds holding ISRG
Front Row Advisors's ISRG Position: Q2 2026 in Review
Front Row Advisors increased its Intuitive Surgical (ISRG) stake by 0.67% in Q2 2026, buying an estimated $18.8K and bringing the position to 6,455 shares worth $2.59M. The position accounts for 0.75% of the portfolio, ranked #36.
Front Row Advisors first reported a position in ISRG in Q4 2017 and has held it in 31 quarters since. The position peaked at $4.04M in Q2 2025. 2,250 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.
- Front Row Advisors held 6,455 shares of Intuitive Surgical worth $2.59M as of Q2 2026.
- Front Row Advisors bought 43 Intuitive Surgical shares in Q2 2026, an estimated $18.8K.
- Intuitive Surgical made up 0.75% of Front Row Advisors's portfolio in Q2 2026, its #36 holding.
- Front Row Advisors first reported a position in Intuitive Surgical in Q4 2017 and has held it in 31 quarters since.
- Front Row Advisors's Intuitive Surgical position peaked at $4.04M in Q2 2025.
- 2,250 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.
Based on Front Row Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.